DA agonists - Overview

Movement Disorders

Volumn 17, Issue SUPPL. 4, 2002, Pages

  Goetz, C G ^a   Koller, W C ^a   Poewe, W ^a   Rascol, O ^a   Sampaio, C ^a   Brin, M F ^a   Lees, Andrew J ^a   LeWitt, P ^a   Lozano, A ^a   Mizuno, Y ^a   Nutt, J ^a   Oertel, W ^a   Olanow, C W ^a   Tolosa, E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; APOMORPHINE; BROMOCRIPTINE; CABERGOLINE; CARBOXYLYASE; DIHYDROERGOCRYPTINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FREE RADICAL; LEVODOPA; LISURIDE; NEUROTRANSMITTER; PERGOLIDE; PIRIBEDIL; PRAMIPEXOLE; PRESYNAPTIC RECEPTOR; ROPINIROLE;

ARTICLE; BASAL GANGLION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DYSKINESIA; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; METHODOLOGY; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 17144465591     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.5561     Document Type: Article

References (0)